Feifei Sun on Muck Rack

Feifei Sun

  • Brand Communications, McKinsey and Company
As seen in: HuffPost, Nature, TIME, Wiley Online Library, PLOS, heart, Journal of Clinical Pathology, Journal of Medical Genetics (JMG), MDPI, Slate and
not the supermodel. writer + editor / previously @time, @vanityfair
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Feifei

Contact Feifei, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Lorlatinib monotherapy or combination therapy in anaplastic lymphoma kinase–driven high-risk neuroblastoma

|
By Weiji Xie, Yu Zhang, Suying Lu, Feifei Sun, Jia Zhu, Yi Que, Junting Huang, Mengjia Song, Zijun Zhen, Juan Wang, Yizhuo Zhang
| Nature
Abstract This study evaluated the clinical efficacy and safety of lorlatinib in 25 patients with anaplastic lymphoma kinase (ALK) -driven neuroblastoma. Among 17 evaluable patients, the objective response rate (ORR) was 64.7% (11/17). All six newly diagnosed high-risk patients who received lorlatinib in combination with induction chemotherapy achieved an objective response.
Open in Who Shared Issue with article?

CAMK1D activates AMPK/PINK1/Parkin-dependent mitophagy to promote enzalutamide resistance in prostate cancer - Cell Death & Disease

|
By Feifei Sun, Lin Gao, Xianhao Shao
| Nature
Abstract Although androgen receptor (AR)-targeted therapies, such as enzalutamide, initially improve outcomes of prostate cancer (PCa) patients, resistance inevitably develops, partly driven by prostate cancer stem-like cells (PCSCs). However, the molecular mechanisms linking the maintenance of PCSCs to enzalutamide resistance (ENZR) remain incompletely elucidated. Here, we implicate Ca²⁺/calmodulin-dependent protein kinase 1D (CAMK1D) in PCSC-mediated ENZR.
Open in Who Shared Issue with article?

Bioequivalence Study of Tadalafil Oral Soluble Film and Tadalafil Tablet in Healthy Chinese Volunteers Under Fasting Conditions

|
By Xin Jiang, Feifei Sun, Ping Shi, Xingli Gu
| Wiley Online Library
1 Introduction Erectile dysfunction (ED) is a common disease in andrology, which brings about not only an unsatisfactory sexual experience but also mental distress. The prevalence of ED increased from 6% to 64% with age [1], and it was predicted that the ED-affected population worldwide would increase to about 322 million by 2025 [2]. In the treatment of ED, phosphodiesterase 5 (PDE5) inhibitors have become the first-line choice [3].
Open in Who Shared Issue with article?
See all 117 licensed articles (119 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Feifei

Contact Feifei, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified